Loading stock RS ticker…
Loading featured RS headlines…
← Back to News
RS ArticleMar 11, 2026, 10:41 AMABT

Abbott (ABT): The long-term value stock opportunity you shouldn't miss.

For investors aiming to build portfolios with strong, market-beating stocks, employing a robust analytical framework is essential. Identifying companies with s…

Abbott (ABT): The long-term value stock opportunity you shouldn't miss.
Article Body

For investors aiming to build portfolios with strong, market-beating stocks, employing a robust analytical framework is essential. Identifying companies with solid fundamentals and favorable market trends can be a key differentiator in achieving superior investment returns.

For Abbott Laboratories (ABT), our quantitative analysis assigns an RS Score of 67.71, placing it in the 50.39th percentile within its country and the 47.47th percentile within its sector. The stock demonstrates strong performance in several key areas, with section scores of 87.44 for Valuation, 89.43 for Growth, 82.82 for Profitability, and 85.00 for EPS Revisions. However, its Momentum score of 11.26 indicates a weaker performance in that specific factor. Want to discover which stocks rank the highest? Start your free 7-day trial at rankedstocks.com.